Literature DB >> 9832439

Adipose tissue-derived tumor necrosis factor activity correlates with fat cell size but not insulin action in aging rats.

C L Morin1, E C Gayles, D A Podolin, Y Wei, M Xu, M J Pagliassotti.   

Abstract

Adipose tissue-derived tumor necrosis factor (AT-TNF) protein and messenger RNA (mRNA) has been shown to correlate with insulin resistance in some studies. However, in a study using different aged Fischer 344 rats, AT-TNF activity correlated more strongly with cell size than with fasting plasma insulin. The present study was undertaken to more carefully examine the relationship among AT-TNF, adipose cell size, and insulin action using more precise measures of insulin action. Basal and hyperinsulinemic, euglycemic clamps were performed in male Sprague Dawley rats at four different ages (8, 13, 21, and 61 weeks old). [3-(3)H]glucose and 2-deoxy-D-[1-(14)C]glucose were used to assess glucose kinetics and tissue-specific glucose uptake. Because TNF activity represents the summation of TNF synthesis, secretion, and the amount of soluble inhibitors present, TNF activity was measured using a bioassay, in addition to measuring TNF protein and mRNA levels. AT-TNF activity increased significantly with age, as did the glucose infusion rate, a measure of whole body insulin resistance. However, AT-TNF activity did not correlate with any parameter of insulin action measured during the hyperinsulinemic, euglycemic clamps. In epididymal fat, AT-TNF activity correlated with: glucose infusion rate: r = -0.50, P = 0.17; rate of appearance: r = -0.19, P = 0.35; rate of disappearance: r = 0.08, P = 0.69. As was noted before, AT-TNF activity correlated well with fat cell size (r = 0.76, P < 0.001 in epididymal fat; r = 0.58, P = 0.007 in SUB fat). These data suggest that although AT-TNF activity and insulin resistance increase with age, the two are not functionally related. These data do not eliminate the potential role of nonadipose TNF in the regulation of insulin action.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9832439     DOI: 10.1210/endo.139.12.6369

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  6 in total

1.  EGFL6 is increasingly expressed in human obesity and promotes proliferation of adipose tissue-derived stromal vascular cells.

Authors:  Rupert Oberauer; Wolfgang Rist; Martin C Lenter; Bradford S Hamilton; Heike Neubauer
Journal:  Mol Cell Biochem       Date:  2010-06-25       Impact factor: 3.396

2.  Adipose-specific disruption of autotaxin enhances nutritional fattening and reduces plasma lysophosphatidic acid.

Authors:  Rodolphe Dusaulcy; Chloé Rancoule; Sandra Grès; Estelle Wanecq; André Colom; Charlotte Guigné; Laurens A van Meeteren; Wouter H Moolenaar; Philippe Valet; Jean Sébastien Saulnier-Blache
Journal:  J Lipid Res       Date:  2011-03-18       Impact factor: 5.922

3.  Lower weight gain and higher expression and blood levels of adiponectin in rats fed medium-chain TAG compared with long-chain TAG.

Authors:  Hiroyuki Takeuchi; Osamu Noguchi; Seiji Sekine; Aiko Kobayashi; Toshiaki Aoyama
Journal:  Lipids       Date:  2006-02       Impact factor: 1.880

4.  Cancer cachexia prevention via physical exercise: molecular mechanisms.

Authors:  Douglas W Gould; Ian Lahart; Amtul R Carmichael; Yiannis Koutedakis; George S Metsios
Journal:  J Cachexia Sarcopenia Muscle       Date:  2012-12-13       Impact factor: 12.910

Review 5.  Adipose tissue aging: mechanisms and therapeutic implications.

Authors:  Min-Yi Ou; Hao Zhang; Poh-Ching Tan; Shuang-Bai Zhou; Qing-Feng Li
Journal:  Cell Death Dis       Date:  2022-04-04       Impact factor: 9.685

Review 6.  The role of TNF-alpha in insulin resistance.

Authors:  Stephen E Borst
Journal:  Endocrine       Date:  2004 Mar-Apr       Impact factor: 3.925

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.